Eli Lilly to Pull Cancer Drug From Market After Failed Study

📆 25/04/2019 18:00:00
📰 WSJ

⏱ Reading Time:
18 sec. here
2 min. at publisher
📊 Quality Score:
News: 11%
Publisher: 63%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

Eli Lilly plans to withdraw its cancer drug Lartruvo from the market after a study showed it failed to prolong overall survival

Eli Lilly & Co. said Thursday it plans to withdraw its cancer drug Lartruvo from the market after a study showed that it failed to prolong overall survival in a clinical trial.

The company will establish an access program to allow some patients with soft-tissue sarcoma—a cancer that develops in connective tissue including muscle—to continue taking the drug with limited interruption after it’s withdrawn from the market. Lilly didn’t provide a specific timeline and said it’s working with health regulators on its plans.

Escrever Comentário

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Stock market fails to extend climb to records as energy-sector retreat weighsThe S&P 500 and the Nasdaq Composite indexes on Wednesday failed to extend their climb into record territory as a pullback in the mostly buoyant energy...
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »